Future Directions for Cxbladder Triage and Microhematuria Evaluation

Yair Lotan, MD, of UT Southwestern, discusses risk stratification in the STRATA trial and outlines the next steps for integrating Cxbladder triage into clinical workflows, including the potential for expanding its use beyond low-risk patients to include intermediate- and high-risk populations. He emphasizes that future guideline updates will likely depend on the performance of markers in ongoing and upcoming trials.